ASLAN Pharmaceuticals Limited Share Price Taipei Exchange
Equities
6497
KYG054241099
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 339M 10.43M 871M |
---|---|---|---|---|---|
Net income 2024 * | -2.14B -65.73M -5.49B | Net income 2025 * | -1.82B -56M -4.67B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.13
x | P/E ratio 2025 * |
-0.19
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 01/10/01 | |
Director of Finance/CFO | 45 | 01/10/01 | |
Chief Tech/Sci/R&D Officer | - | 15/22/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
BRD | Director/Board Member | 58 | 30/18/30 |
Chairman | 64 | 01/16/01 | |
Founder | 51 | 01/10/01 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |